Actively Recruiting
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
Led by Peking University First Hospital · Updated on 2024-08-15
100000
Participants Needed
1
Research Sites
539 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In order to further improve the diagnosis and treatment level of type 2 inflammatory skin diseases, the National Clinical Center for Skin and Immune Diseases established a standardized diagnosis and treatment center for type 2 inflammatory skin diseases to systematically and effectively understand the current treatment status of patients with type 2 inflammatory skin diseases, as well as the efficacy and safety of various treatment methods during practices, so as to further improve the diagnosis and treatment level of type 2 inflammatory skin diseases and help patients with type 2 inflammatory skin diseases.
CONDITIONS
Official Title
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients from medical units approved by the National Clinical Center for Skin and Immune Diseases for data collection
- Diagnosed with type 2 inflammatory skin diseases including dermatitis/eczema, urticaria, pemphigoid, or prurigo nodularis
You will not qualify if you...
- Unable or unwilling to provide informed consent
- Unable to complete questionnaires independently or with guidance from investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University First Hospital
Beijing, China
Actively Recruiting
Research Team
Y
Yang Wang, Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here